Cleared Special

K062994 - LATERALIZED TAPERLOC MICROPLASTY FEMORAL COMPONENTS (FDA 510(k) Clearance)

Mar 2007
Decision
158d
Days
Class 3
Risk

K062994 is an FDA 510(k) clearance for the LATERALIZED TAPERLOC MICROPLASTY FEMORAL COMPONENTS. This device is classified as a Prosthesis, Hip, Semi-constrained (metal Uncemented Acetabular Component) (Class III - Premarket Approval, product code KWA).

Submitted by Biomet Manufacturing Corp (Warsaw, US). The FDA issued a Cleared decision on March 9, 2007, 158 days after receiving the submission on October 2, 2006.

This device falls under the Orthopedic FDA review panel. Regulated under 21 CFR 888.3330.

Submission Details

510(k) Number K062994 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 2006
Decision Date March 09, 2007
Days to Decision 158 days
Submission Type Special
Review Panel Orthopedic (OR)
Summary Summary PDF

Device Classification

Product Code KWA — Prosthesis, Hip, Semi-constrained (metal Uncemented Acetabular Component)
Device Class Class III - Premarket Approval
CFR Regulation 21 CFR 888.3330